Skip to main content

Table 2 Number of patients who achieved target blood glucose levels after 21 days of dietary treatment

From: The effect of the macrobiotic Ma-Pi 2 diet vs. the recommended diet in the management of type 2 diabetes: the randomized controlled MADIAB trial

 

Ma-Pi 2 diet (n. 25)

Control diet (n. 26)

 

95% CI*

Fasting blood glucose (target value ≤ 110 mg/dl)

n (%)

n (%)

Difference (%)

LL

UL

Target achievement**

19 (100)

9 (45)

55.00

33.20

76.80

Target maintenance**

6 (100)

5 (83.33)

16.67

−13.15

46.49

Post-prandial blood glucose (target value ≤ 140 mg/dl)

     

Target achievement

11 (100)

8 (53.33)

46.67

21.42

71.91

Target maintenance

14 (100)

9 (81.82)

18.18

−4.61

40.97

  1. *McNemar test. Coefficients are statistically significant when the 95% CI’s does not include zero.
  2. **The percentage of patients that achieved the glycemic target level (both fasting and 2-h after lunch capillary glucose) between T0 and T21 and the percentage of patients that maintained the glycemic target level (both fasting and 2-h after lunch capillary glucose) between T0 and T21, in the Ma-Pi 2 group compared with the control group.